Effects of dietary mixtures of amino acids on fetal growth and maternal and fetal amino acid pools in experimental maternal phenylketonuria

American Journal of Clinical Nutrition

Volumn 69, Issue 4, 1999, Pages 687-696

  Austic, Richard E ^a   Su, Chun Li ^a   Strupp, Barbara J ^a   Levitsky, David A ^a  

^a Cornell University ^*  (United States)

Author keywords

Amino acids; Brain; DL methylphenylalanine; Fetus; Gestation; Large neutral amino acids; Phenylalanine; Phenylketonuria; Plasma; Rats

Indexed keywords

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ARTICLE; BRAIN GROWTH; DIET SUPPLEMENTATION; FETUS; FETUS GROWTH; NONHUMAN; PHENYLKETONURIA; PLACENTAL TRANSFER; PROTEIN INTAKE; RAT;

ANIMALIA;

EID: 0032955206     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.4.687     Document Type: Article

References (40)

1. Mabry CC, Denniston JC, Nelson TL, Son CD. Maternal phenylketonuria. A cause of mental retardation in children without the metabolic defect. N Engl J Med 1963;269:1404-8.
2. Lenke RR, Levy HL. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med 1980;303:1202-8.
3. Rouse B, Lockhart L, Matalon R, et al. Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations. J Inherit Metab Dis 1990;13:289-91.
4. Lenke RR, Levy HL. Maternal phenylketonuria - results of dietary therapy. Am J Obstet Gynecol 1982;142:548-53.
5. Koch R, Hanley W, Levy H, et al. A preliminary report of the collaborative study of maternal phenylketonuria in the United States and Canada. J Inherit Metab Dis 1990;13:641-50.
6. Smith I, Glossop J, Beasley M. Fetal damage due to maternal phenylketonuria: effects of dietary treatment and maternal phenylalanine concentrations around the time of conception. J Inherit Metab Dis 1990;13:651-7.
7. Drogari E, Beasley M, Smith I, Lloyd JK. Timing of strict diet in relation to fetal damage in maternal phenylketonuria. Lancet 1987;2:927-30.
8. Pueschel SM, Hum C, Andrews M. Nutritional management of the female with phenylketonuria during pregnancy. Am J Clin Nutr 1977;30:1153-61.
9. Kecskemethy HH, Lobbregt D, Levy HL. The use of gelatin capsules for ingestion of formula in dietary treatment of maternal phenylketonuria. J Inherit Metab Dis 1993;16:111-8.
10. Andersen AE, Avins L. Lowering brain phenylalanine levels by giving other large neutral amino acids. Arch Neurol 1976;33:684-6.
11. Berry HK, Bofinger MK, Hunt MM, Phillips PJ, Guilfoile MB. Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine, and leucine. Pediatr Res 1982;16:751-5.
12. Binek-Singer P, Johnson TC. The effects of chronic hyperphenylalaninaemia on mouse brain protein synthesis can be prevented by other amino acids. Biochem J 1982;206:407-14.
13. Berry HK, Butcher RE, Brunner RL, Bray NW, Hunt MM, Wharton CH. New approaches to treatment of phenylketonuria. In: Mittler P, ed. Research to practice in mental retardation. Biomedical aspects. Vol 3. Baltimore: University Park Press, 1977:229-39.
14. Brunner RL, Vorhees CV, McLean MS, Butcher RE, Berry HK. Beneficial effect of isoleucine on fetal brain development in induced phenylketonuria. Brain Res 1978;154:191-5.
15. McSwigan JD, Vorhees CV, Brunner RL, Butcher RE, Berry HK. Amelioration of maze deficits from induced hyperphenylalaninemia in adult rats using valine, isoleucine, and leucine. Behav Neural Biol 1981;33:378-84.
16. Vorhees CV, Acuff-Smith KD, Weisenburger WP, Minck DR, Berry HK. Branched chain amino acids improve radial-arm maze acquisition and water maze forced-choice learning in rat offspring exposed in utero to hyperphenylalaninemia. Neurotoxicol Teratol 1992;14:35-41.
17. Kelly CJ, Johnson TC. Effects of p-chlorophenylalanine and α-methylphenylalanine on amino acid uptake and protein synthesis in mouse neuroblastoma cells. Biochem J 1978;174:931-8.
18. Delvalle JA, Dienel G, Greengard O. Comparison of a-methylphenylalanine and p-chlorophenylalanine as inducers of chronic hyperphenylalaninaemia in developing rats. Biochem J 1978;170:449-59.
19. Lane JD, Schöne B, Langenbeck U, Neuhoff V. Characterization of experimental phenylketonuria. Augmentation of hyperphenylalaninemia with α-methylphenylalanine and p-chlorophenylalanine. Biochim Biophys Acta 1980;627:144-56.
20. Koe BK, Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 1966;154:499-516.
21. Brass CA, Isaacs CE, McChesney R, Greengard O. The effects of hyperphenylalaninemia on fetal development: a new animal model of maternal phenylketonuria. Pediatr Res 1982;16:388-94.
22. Hanulak AT, Hull EM. Behavioral deficits in a rat model of maternal PKU. Psychobiology 1987;15:75-8.
23. Sadava D, Sutcliffe D. The effects of maternal hyperphenylalaninemia on learning in mature rats. Life Sci 1988;43:1119-23.
24. Strupp BJ, Bunsey M, Levitsky DA, Hamberger K. Deficient cumulative learning: an animal model of retarded cognitive development. Neurotoxicol Teratol 1994;16:71-9.
25. Ad Hoc Committee on Standards for Nutritional Studies. Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 1977;107:1340-8.
26. Ad Hoc Committee on Standards for Nutritional Studies. Second report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 1980;110:1726.
27. Umbreit WW. Reactions of α-methyl amino acids. In: McElroy WD, Glass HB, eds. A symposium on amino acid metabolism. Baltimore: The Johns Hopkins Press, 1955;48-54.
28. Lerner MP, Johnson TC. Regulation of protein synthesis in developing mouse brain tissue. Alteration in ribosomal activity. J Biol Chem 1970;245:1388-93.
29. Lowry OH, Rosebrough NJ, Fan AL. Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
30. SAS Institute, Inc. SAS user's guide: statistics, version 5 ed. Cary, NC: SAS Institute, Inc, 1985.
31. Su C-L, Austic RE, Strupp BJ, Levitsky DA. Improved model of maternal phenylketonuria in rats by use of lower dietary concentrations of α-methylphenylalanine and L-phenylalanine in a semipurified diet. Nutr Res 1998;18:989-1002.
32. Dienel GA. Chronic hyperphenylalaninemia produces cerebral hyperglycinemia in immature rats. J Neurochem 1981;36:34-43.
33. Huether G, Kaus R, Neuhoff V. Amino acid depletion in the blood and brain tissue of hyperphenylalaninemic rats is abolished by the administration of additional lysine : a contribution to the understanding of the metabolic defects in phenylketonuria. Biochem Med 1985;33:334-41.
34. Hughes JV, Johnson TC. Experimentally-induced and natural recovery from the effects of phenylalanine on brain protein synthesis. Biochim Biophys Acta 1978;517:473-85.
35. Davis AJ, Austic RE. Dietary protein and amino acid levels alter threonine dehydrogenase activity in hepatic mitochondria of Callus domesticus. J Nutr 1997;127:738-44.
36. Bird MI, Nunn PB, Lord LAJ. Formation of glycine and aminoacetone from L-threonine by rat liver mitochondria. Biochim Biophys Acta 1984;802:229-36.
37. Ballèvre O, Cadenhead A, Calder AG, et al. Quantitative partition of threonine oxidation in pigs: effect of dietary threonine. Am J Physiol 1990;259:E483-91.
38. Leung PM-B, Rogers QR, Harper AE. Effect of amino acid imbalance on plasma and tissue free amino acids in the rat. J Nutr 1968;96:303-18.
39. Tews JK, Kim Y-WL, Harper AE. Induction of threonine imbalance by dispensable amino acids: relation to competition for amino acid transport into brain. J Nutr 1979;109:304-15.
40. Davis AJ. Austic RE. Dietary threonine imbalance alters threonine dehydrogenase activity in isolated hepatic mitochondria of chicks and rats. J Nutr 1994;124:1667-77.